Abstract: A method and apparatus for banding collagen condoms. An elastic band is incorporated into the collagen gel body of the condom as an integral part thereof. The band is sealed within adjacent layers of collagen film, made from collagen gel, the layers of film forming the condom body.

Abstract: An apparatus for making parts having complex geometric shapes by injection molding apparatus. The apparatus avoids the formation of a parting line in the molded object. The apparatus includes an injector plate, an ejector plate and a floating plate. The injector plate has at least one mold cavity for making a part and a passageway to allow molten plastic to enter the mold cavity. The ejector plate has at least one mold cavity corresponding to the mold cavity in the injector plate. The floating plate has at least one projection. The plates are adapted to fit together when the mold is closed so that the floating plate is between the injector and ejector plates and the projection fits centrally between the cavities of the injector and ejector plates. A mechanism moves the injector plate, ejector plate and floating plate with respect to one another.

Abstract: The present invention relates to a collagen gel and to a process for obtaining it. More particularly, the present invention relates to an improved homogeneous collagen gel, which can be used in the manufacture of collagen film articles of improved thinness, smoothness, superior strength, and superior homogeneity, and to a process for obtaining the improved gel.

Abstract: A spermicidally active, lubricated prophylactic and method for making same is disclosed. The prophylactic is formed by dip-coating and unrolling the prophylactic and a specific lubricant, polyethylene glycol, and a spermicide are dispensed into the rolled prophylactic, the lubricant causing migration of the spermicide throughout the rolled device.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of candimycin. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: Orally administered compositions for treating prostatic hypertrophy are described herein, these compositions containing an effective dose of heptamycin. Also, the method of treating prostatic hypertrophy with such compositions is described herein.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of antibiotic SCH-16656. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level is described herein.

Abstract: A method of increasing the overall effectiveness, including stability and gastrointestinal tolerability, of a polyenic macrolide selected from the class consisting of candicidin, fungimycin, hamycin and mediocidin is described which comprises orally administering the polyenic macrolide with an absorbent material. Compositions containing a polyenic macrolide and a suitable absorbent material preferably in beadlet form are described for use in treating various conditions including prostate hypertrophy, hypercholesterolemia and acne.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of Levorin. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: Orally administered compositions for treating prostatic hypertrophy are described herein. These compositions contain an effective dose of a pharmaceutical formulation containing antibiotic SCH-16656. Also, the method of treating prostatic hypertrophy with such compositions is described herein.

Abstract: A method of increasing the overall effectiveness, including stability and gastrointestinal tolerability, of a polyenic macrolide selected from the class consisting of candicidin, fungimycin, hamycin and mediocidin is described which comprises orally administering the polyenic macrolide with an absorbent material. Compositions containing a polyenic macrolide and a suitable absorbent material preferably in beadlet form are described for use in treating various conditions including prostate hypertrophy, hypercholesterolemia and acne.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of a pharmaceutical formulation having a molecular structure including a polyenic macrolide nucleus having at least five conjugated double bonds. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of N-acetyl candicidin. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: Orally administered compositions for treating prostatic hypertrophy are described herein, these compositions containing an effective dose of a pharmaceutical formulation containing N-acetyl candicidin. Also, the method of treating prostatic hypertrophy with such compositions, is described herein.